SETUP

MET is breaking out at a 52-week high of $87.85, confirming a clean technical breakout above $87.68. This is meaningful because 52-week high breakouts signal the exhaustion of prior resistance and often lead to price discovery in open air. The stock has already gapped up 1.44% today on 1.31x average volume, which is supportive but not explosive. Volume confirmation is moderate, not exceptional. The breakout is fresh and the signal price aligns with live price, suggesting the trade is still actionable at current levels.

CATALYSTS

Insurance sector is benefiting from elevated interest rates sustaining investment income, a core earnings driver for life insurers like MetLife. The macro environment of higher-for-longer rates remains a structural tailwind for the group. Insider activity shows multiple officers and directors acquiring shares in Q1-Q2 2026, including a notable purchase by officer Marlene Debel across two separate transactions totaling over $2.7M in value, which signals internal confidence at elevated price levels. Next earnings are not until May 2026, removing near-term earnings event risk.

RISKS

Three consecutive earnings misses are a real concern, with the October 2024 miss being a significant -10.1% shortfall. Execution risk is clearly present. The dividend figure of 275% appears anomalous and may reflect a data error rather than a true yield, which should be verified before sizing up. The risk/reward of 1:1.89 is acceptable but not compelling for a 52-week high breakout where overhead resistance is unknown. A failure to hold $87.68 on any intraday reversal would quickly flip this from breakout to false breakout, and the stop at $86.25 represents a $1.60 risk per share.

CONVICTION: Medium

The technical setup is clean and insider buying is supportive, but repeated earnings misses and modest volume on the breakout limit confidence in follow-through.